Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology
- PMID: 27041930
- PMCID: PMC4779762
- DOI: 10.3978/j.issn.1000-9604.2016.02.09
Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology
Abstract
Clear cell renal cell carcinoma (ccRCC) is one frequent form of urologic malignancy with numerous genetic and epigenetic alterations. This review summarizes the recent major findings of epigenetic alterations including DNA methylation, histone modifications, microRNAs and recently identified long noncoding RNAs in the development and progression of ccRCC. These epigenetic profilings can provide a promising means of prognostication and early diagnosis for patients with ccRCCs. With the developed high-throughput technologies nowadays, the epigenetic analyses will have possible clinical applications in the molecular pathology of ccRCC.
Keywords: DNA methylation; clear cell renal cell carcinoma (ccRCC); histone modification; long noncoding RNA; microRNA.
Conflict of interest statement
Figures
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29. - PubMed
-
- Patel AR, Prasad SM, Shih YC, et al. The association of the human development index with global kidney cancer incidence and mortality. J Urol 2012;187:1978-83. - PubMed
-
- Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002;16:6-21. - PubMed
-
- Beyond the genome. Nature 2015;518:273. - PubMed
-
- Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 2012;22:50-5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources